Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Genomics

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Radiation: Applications

Radiation: Applications

The average temperature of Earth is the subject of much current discussion. Earth is in radiative contact with both the Sun and dark space; it receives almost all its energy from the radiation of the Sun and reflects some of it into outer space. Dark space is very cold, about 3 K, so Earth radiates energy into it. For instance, heat transfer occurs from soil and grasses, the rate of which can be so rapid that frost can occur on clear summer evenings, even in warm latitudes.
The average...

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reirradiation Options for Previously Irradiated Prostate Cancer: Is It Feasible to Randomise Between Treatment With Stereotactic Body Radiotherapy (SBRT) Versus High-Dose-Rate Brachytherapy?

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Same author

The Use of Radiotherapy in the Cure of Different Cancers - Further Results From the FORTY (Favourable Outcomes From RadioTherapY) Project.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025

Same author

Corrigendum to "Bereaved family members' perspectives of their organ donation decision at three months post death of the donor-eligible patient in critical care: A qualitative enquiry" [Aust. Crit. Care 38 (2025) 101132].

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2025

Same author

Best Practice for Patient-centred Radiotherapy in Clinical Trials and Beyond-A National Multidisciplinary Consensus.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025

Same author

Proton Beam Therapy in the Reirradiation Setting of Brain and Base of Skull Tumour Recurrences.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023

Same author

Assessing Equity of Access to Proton Beam Therapy: A Literature Review.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

The genomics revolution and radiotherapy.

C M L West¹, R M Elliott, N G Burnet

¹Academic Radiation Oncology, University of Manchester, Christie Hospital NHS Trust, Manchester M20 4BX, UK. catharine.west@manchester.ac.uk

Clinical Oncology (Royal College of Radiologists (Great Britain))

|April 10, 2007

Summary

High-throughput technologies and genomic advancements are paving the way for personalized medicine. This progress aims to improve the prediction of individual patient responses to radiotherapy in clinical oncology.

More Related Videos

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on: April 5, 2024

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Experiment Videos

Last Updated: Jul 15, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids

Published on: April 5, 2024

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Area of Science:

Genomics
Oncology
Radiotherapy

Background:

The Human Genome Project expanded knowledge, driving the development of high-throughput techniques for large-scale gene and genome analysis.
These advanced assays analyze DNA (genome), RNA (transcriptome), and protein (proteome) levels in clinical samples.

Purpose of the Study:

To review the impact of genomic advancements and new technologies on personalized medicine, particularly in clinical oncology.
To highlight research on sparsely ionizing radiation and its integration with novel technologies for predicting radiotherapy response.

Main Methods:

Review of current literature on high-throughput technologies in genomics.
Analysis of studies linking genomic data to patient response to radiotherapy.
Exploration of advancements in sparsely ionizing radiation techniques.

Main Results:

High-throughput sequencing and genomic analysis enable a deeper understanding of individual variability.
These technologies hold promise for predicting patient responses to specific cancer treatments like radiotherapy.
Integration of genomic data with radiation technology is advancing personalized oncology.

Conclusions:

The genomic revolution is a key driver for the future of personalized medicine in oncology.
Predicting individual patient responses to radiotherapy is becoming increasingly feasible through technological advancements.
Further research integrating new technologies with sparsely ionizing radiation is crucial for clinical applications.